SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,577.55 215.03
(0.46%)

Dow Jones

6,594.89 45.37
(0.69%)

Hang Seng

52,384.74 -1,354.94
(-2.52%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.85 -0.46
(-0.49%)

EUR-INR

107.97 -0.33
(-0.30%)

GBP-INR

124.03 -0.65
(-0.52%)

JPY-INR

0.59 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

233.44

52.1

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Vaxtex Cotfab reports standalone net profit of Rs 3.95 crore in the December 2025 quarter

Feb 12,2026

Net profit of Vaxtex Cotfab reported to Rs 3.95 crore in the quarter ended December 2025 as against net loss of Rs 0.39 crore during the previous quarter ended December 2024. Sales reported to Rs 8.88 crore in the quarter ended December 2025. There were no Sales reported during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8.88	0	0
OPM %	26.13	0	-
PBDT	3.86	-0.38	LP
PBT	3.86	-0.44	LP
NP	3.95	-0.39	LP

73,319.55 185.23 ( 0.25%)

46,577.55 215.03 (0.46%)

6,594.89 45.37 (0.69%)

52,384.74 -1,354.94 (-2.52%)

10,436.29 71.50 (0.69%)

93.85 -0.46 (-0.49%)

107.97 -0.33 (-0.30%)

124.03 -0.65 (-0.52%)

0.59 0.00 (-0.26%)